Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Altinicline

From Wikipedia, the free encyclopedia
(Redirected fromSIB-1508Y)
Chemical compound
Pharmaceutical compound
Altinicline
Clinical data
ATC code
  • None
Identifiers
  • (2S)-3-ethynyl-5-(1-methylpyrrolidin-2-yl)pyridine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC12H14N2
Molar mass186.258 g·mol−1
3D model (JSmol)
  • c2ncc(C#C)cc2C1CCCN1C
  • InChI=1S/C12H14N2/c1-3-10-7-11(9-13-8-10)12-5-4-6-14(12)2/h1,7-9,12H,4-6H2,2H3/t12-/m0/s1 checkY
  • Key:NUPUDYKEEJNZRG-LBPRGKRZSA-N checkY
  (verify)

Altinicline (SIB-1508Y,SIB-1765F) is a drug which acts as anagonist at neuralnicotinic acetylcholine receptors with high selectivity for theα4β2 subtype.[1][2] It stimulates release ofdopamine andacetylcholine in the brain in both rodent and primate models,[3] and progressed as far as Phase IIclinical trials forParkinson's disease,[4] where "no antiparkinsonian or cognitive-enhancing effects were demonstrated", although its current status is unclear.

References

[edit]
  1. ^Cosford ND, Bleicher L, Vernier JM, Chavez-Noriega L, Rao TS, Siegel RS, et al. (March 2000). "Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist".Pharmaceutica Acta Helvetiae.74 (2–3):125–30.doi:10.1016/S0031-6865(99)00024-2.PMID 10812948.
  2. ^Wagner FF, Comins DL (October 2006). "Expedient five-step synthesis of SIB-1508Y from natural nicotine".The Journal of Organic Chemistry.71 (22):8673–5.doi:10.1021/jo0616052.PMID 17064057.
  3. ^Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Cosford ND (October 2008). "Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist".Brain Research.1234:16–24.doi:10.1016/j.brainres.2008.07.063.PMID 18692487.S2CID 23547813.
  4. ^The Parkinson Study Group (February 2006). "Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease".Neurology.66 (3):408–10.doi:10.1212/01.wnl.0000196466.99381.5c.PMID 16476941.S2CID 31720763.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(andPAMsTooltip positive allosteric modulators)
Antagonists
(andNAMsTooltip negative allosteric modulators)
Precursors
(andprodrugs)


Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Altinicline&oldid=1295587741"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp